HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Fujimura, S. Articles by Watanabe, A. Search for Related Content PubMed PubMed Citation Articles by Fujimura, S. Articles by Watanabe, A. Agricola Articles by Fujimura, S. Articles by Watanabe, A.

In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children

¹Department of Microbiology, Miyagi University, 1 Gakuen, Taiwa-cho, Miyagi, 981-3298, Japan ²Department of Pediatrics, Tohoku University School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai, Japan ³Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Ageing and Cancer, Tohoku University, 4-1, Seiryo-machi, Aoba-ku, Sendai, Japan

Correspondence Shigeru Fujimura hujimura{at}myu.ac.jp

Received February 25, 2004
Accepted May 27, 2004

Resistance to antibiotics, especially clarithromycin, is the major cause of the failure to eradicate Helicobacter pylori. There are few studies in children concerning fluoroquinolone activity against H. pylori. Primary resistance to antibiotics including fluoroquinolones was studied in 55 H. pylori strains isolated from Japanese children. DNA sequences of the gyrA gene in fluoroquinolone-resistant strains were determined. Twelve strains (21.8 %) were resistant to clarithromycin and three (5.5 %) were resistant to both levofloxacin and ciprofloxacin. Out of 12 clarithromycin-resistant strains, 11 (91.7 %) were susceptible to levofloxacin and ciprofloxacin. Sequence analysis in three fluoroquinolone-resistant strains showed point mutations of the gyrA gene at G271A, G271T and A272G, indicating mutations of the codon Asp91 in the fluoroquinolone-resistance-determining region of the DNA gyrase. The results suggest that fluoroquinolones should be considered as an option for second- or third-line H. pylori eradication therapy in children.

This article has been cited by other articles:

				T. Nishizawa, H. Suzuki, A. Umezawa, H. Muraoka, E. Iwasaki, T. Masaoka, I. Kobayashi, and T. Hibi Rapid Detection of Point Mutations Conferring Resistance to Fluoroquinolone in gyrA of Helicobacter pylori by Allele-Specific PCR J. Clin. Microbiol., February 1, 2007; 45(2): 303 - 305. [Abstract] [Full Text] [PDF]

				E. Glocker, H.-P. Stueger, and M. Kist Quinolone Resistance in Helicobacter pylori Isolates in Germany Antimicrob. Agents Chemother., January 1, 2007; 51(1): 346 - 349. [Abstract] [Full Text] [PDF]

				T. Nishizawa, H. Suzuki, K. Kurabayashi, T. Masaoka, H. Muraoka, M. Mori, E. Iwasaki, I. Kobayashi, and T. Hibi Gatifloxacin Resistance and Mutations in gyrA after Unsuccessful Helicobacter pylori Eradication in Japan. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1538 - 1540. [Abstract] [Full Text] [PDF]

				J. M. Kim, J. S. Kim, N. Kim, H. C. Jung, and I. S. Song Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients J. Antimicrob. Chemother., November 1, 2005; 56(5): 965 - 967. [Abstract] [Full Text] [PDF]